Taurine-deficient dilated cardiomyopathy in a family of golden retrievers

Journal of the American Animal Hospital Association

Volumn 41, Issue 5, 2005, Pages 284-291

  Bélanger, Marie C ^a   Ouellet, Mathieu ^a   Queney, Guillaume ^b   Moreau, Maxim ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Antagene Animal Genetics Laboratory   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAURINE;

AMINO ACID DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIET SUPPLEMENTATION; DOG DISEASE; ECHOCARDIOGRAPHY; FEMALE; MALE; NONHUMAN; PEDIGREE ANALYSIS; SYSTOLIC HEART MURMUR; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 31844454117     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0410284     Document Type: Article

References (42)

1. Tenaglia A, Cody R. Evidence for a taurine-deficient cardiomyopathy. Am J Cardiol 1988;62:136-139.
2. Huxtable RJ. From heart to hypothesis: a mechanism for the calcium modulatory actions of taurine. Adv Exp Med Biol 1987;217:371-387.
3. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992;72:101-163.
4. Schaffer S, Solodushko V, Pastukh V. Possible cause of taurine-deficient cardiomyopathy: potentiation of angiotensin II action. J Cardiovasc Pharmacol 2003;41:751-759.
5. Steele DS, Smith GL, Miller DJ. The effect of taurine on calcium uptake by sarcoplasmic reticulum and calcium sensitivity of chemically skinned rat heart. J Physiol 1990;422:499-511.
6. Huxtable RJ, Chubb J, Azari J. Physiological and experimental regulation of taurine content in the heart. Fed Proc 1980;39:2685-2690.
7. Schaffer SW, Kramer J, Chovan JP. Regulation of calcium homeostasis in the heart by taurine. Fed Proc 1980;39:2691-2694.
8. Liu GX, Yang YZ, Gu QB, et al. Effects of taurine on L-type voltage dependent calcium channel in rat cardiomyocytes infected with coxsachievirus B3. Acta Pharmacol Sin 1998;19:238-240.
9. Schaffer SW, Lombardini JB, Azuma J. Interaction between the action of taurine and angiotensin II. Amino Acids 2000;18:305-318.
10. Kajstura J, Cigola E, Malhotra A, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997;29:859-870.
11. Takahashi K, Hashimoto H, Baba A, et al. Effect of taurine on angiotensin II-induced expression of immediate early response genes in primary cultured neonatal rat heart cells. Adv Exp Med Biol 1996;403:297-304.
12. Azuma M, Takahashi K, Fukuda T, et al. Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal cardiac myocytes. Eur J Pharmacol 2000;403:181-188.
13. Hayes KC, Carey RE, Schmidt SY. Retinal degeneration associated with taurine deficiency in the cat. Science 1975;188:949-951.
14. Pion PD, Kitdeson MD, Rogers QR, et al. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 1987;237:764-768.
15. Pion PD, Kittleson MD, DeLellis LA, et al. Persistent recovery of myocardial function in cats with dilated cardiomyopathy secondary to taurine deficiency: one year follow-up. Circulation 1988;178:340.
16. Pion PD, Sanderson SL, Kittleson MD. The effectiveness of taurine and levocarnitine in dogs with heart disease. Vet Clin North Am Small Anim Pract 1998;28:1495-1514.
17. Moise NS, Pacioretty LM, Kalfelz FA, et al. Dietary taurine-deficient and dilated cardiomyopathy in the fox. Am Heart J 1991;121:541-547.
18. Sisson D, O'Grady MR, Calvert CA. Myocardial diseases in the dog. In: Fox PR, Sisson P, Moise NS, eds. Textbook of Canine and Feline Cardiology. 2nd ed. Philadelphia: WB Saunders, 1999:581-619.
19. Alroy J, Rush JE, Freeman L, et al. Inherited infantile dilated cardiomyopathy in dogs: genetic, clinical, biochemical, and morphologic findings. Am J Med Genet 2002;104:262-264.
20. Kittleson MD, Keene B, Pion PD, et al. Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration. J Vet Intern Med 1997;11:204-211.
21. Freeman LM, Michel KE, Brown DJ, et al. Idiopathic dilated cardiomyopathy in Dalmatians: nine cases (1990-1995). J Am Vet Med Assoc 1996;209:1592-1596.
22. Fascetti AJ, Reed JR, Rogers QR, et al. Taurine deficiency in dogs with dilated cardiomyopathy: 12 cases (1997-2001). J Am Vet Med Assoc 2003;223:1137-1141.
23. Dambach DM, Lannon A, Sleeper MM, et al. Familial dilated cardiomyopathy of young Portuguese water dogs. J Vet Intern Med 1999;13:65-71.
24. Olsen TM, Keating MT. Defining the molecular genetic basis of idiopathic dilated cardiomyopathy. Trends Cardiovasc Med 1997;7:60-63.
25. Kramer GA, Kittleson MD, Fox PR, et al. Plasma taurine concentration in normal dogs and in dogs with heart disease. J Vet Intern Med 1995;9:253-258.
26. Morrison SA, Moise NS, Scarlett JM, et al. Effect of breed and body weight on echocardiographic values of four breeds of dogs of differing weight and somatotype. J Vet Intern Med 1992;6:220-224.
27. Meurs KM, Miller MW, Wright NA. Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis: 17 cases (1990-2000). J Am Vet Med Assoc 2001;218:729-732.
28. Chazov EI, Malchikova LS, Lipina NV, et al. Taurine and electrical activity of the heart. Circ Res 1974;35:11-21.
29. Backus RC, Cohen G, Pion PD, et al. Taurine deficiency in Newfoundlands fed commercially available complete and balanced diets. J Am Vet Med Assoc 2003;223:1130-1136.
30. Ganapathy V, Leibach FH. Expression and regulation of the taurine transporter in cultured cell lines of human origin. Adv Exp Med Biol 1994;359:51-57.
31. Tidholm A, Haggstrom J, Borgarelli M, et al. Canine idiopathic dilated cardiomyopathy. Part I: aetiology, clinical characteristics, epidemiology and pathology. Vet J 2001; 162:92-107.
32. Tidholm A, Svenson H, Sylven C. Survival and prognostic factors in 189 dogs with dilated cardiomyopathy. J Am Anim Hosp Assoc 1997;33:364-368.
33. Monnet E, Orton EC, Salam M, et al. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators. J Vet Intern Med 1995;9:12-17.
34. Goodwin JK, Cattiny G. Further characterization of boxer cardiomyopathy. Proceedings, 13th Am Coll Vet Intern Med Forum, Lake Buena Vista, FL, 1995:300.
35. Calvert CA. Diagnosis and management of ventricular arrhythmias in Doberman pinschers with cardiomyopathy. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy XII Small Animal Practice. Philadelphia: WB Saunders, 1995:799-806.
36. Hammer TA, Venta PJ, Eyster GE. The genetic basis of dilated cardiomyopathy in Doberman pinschers. Anim Genet 1996;27:109.
37. Lawler DF, Templeton AJ, Monti KL. Evidence for genetic involvement in feline dilated cardiomyopathy. J Vet Intern Med 1993;7:383-387.
38. Delaney SJ, Kass PH, Rodgers QR, et al. Plasma and whole blood taurine in normal dogs of varying size fed commercially prepared food. J Anim Physiol Anim Nutr (Berl) 2003;87:236-244.
39. Stratton-Phelps M, Backus RC, Rodgers QR, et al. Dietary rice bran decreases plasma and whole-blood taurine in cats. J Nutr 2002;132:1745-1747.
40. Johnson ML, Parsons CM, Fahey GC, et al. Effects of species raw material source, ash content and processing temperature on amino acid digestibility of animal by-product meals by cecectomized and ileally cannulated dogs. J Anim Sci 1998;76:1112-1122.
41. Torres CL, Backus RC, Fascetti AJ, et al. Taurine status in normal dogs fed a commercial diet associated with taurine deficiency and dilated cardiomyopathy. J Anim Physiol Anim Nutr (Berl) 2003;87:359-372.
42. Sanderson S, Osborne C, Gross KL, et al. Reliability of canine plasma and whole blood taurine concentrations as indicators of cardiac and squelettal muscle taurine concentration. J Vet Intern Med 2002;12:224.